Get the Stockscreener App
22.15
5.33%
1.12
After Hours:
21.70
-0.45
-2.03%
Beta Bionics Inc stock is traded at $22.15, with a volume of 447.86K.
It is up +5.33% in the last 24 hours and down -16.13% over the past month.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
See More
Previous Close:
$21.03
Open:
$21.06
24h Volume:
447.86K
Relative Volume:
0.60
Market Cap:
$962.86M
Revenue:
$78.02M
Net Income/Loss:
$-73.37M
P/E Ratio:
-16.78
EPS:
-1.32
Net Cash Flow:
$-62.06M
1W Performance:
+0.91%
1M Performance:
-16.13%
6M Performance:
+103.02%
1Y Performance:
+0.00%
1-Day Range:
$20.80
$22.42
1-Week Range:
$20.80
$23.41
52-Week Range:
$8.89
$26.66
Beta Bionics Inc Stock (BBNX) Company Profile
Name
Beta Bionics Inc
Sector
Industry
Phone
949-427-7785
Address
11 HUGHES, IRVINE
Compare BBNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
22.15 | 914.18M | 78.02M | -73.37M | -62.06M | -1.32 |
|
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-25 | Upgrade | Goldman | Neutral → Buy |
| Jun-16-25 | Initiated | Truist | Buy |
| Jun-12-25 | Initiated | Lake Street | Buy |
| May-30-25 | Initiated | Goldman | Neutral |
| May-30-25 | Initiated | Wolfe Research | Outperform |
| Feb-24-25 | Initiated | BofA Securities | Buy |
| Feb-24-25 | Initiated | Lake Street | Buy |
| Feb-24-25 | Initiated | Leerink Partners | Outperform |
| Feb-24-25 | Initiated | Piper Sandler | Overweight |
| Feb-24-25 | Initiated | Stifel | Buy |
| Feb-20-25 | Initiated | Ladenburg Thalmann | Neutral |
| Feb-20-25 | Initiated | Robert W. Baird | Neutral |
View All
Beta Bionics Inc Stock (BBNX) Latest News
Is Beta Bionics Inc. stock positioned for long term growthWeekly Risk Report & AI Forecast Swing Trade Picks - newser.com
Beta Bionics Inc. stock retracement – recovery analysis2025 Major Catalysts & Capital Efficiency Focused Strategies - newser.com
Short interest data insights for Beta Bionics Inc.July 2025 Review & Weekly Watchlist for Consistent Profits - newser.com
Midday Stock Roundup: EnVVeno down 15% - Orange County Business Journal
Beta Bionics Inc. stock prediction for this week2025 Risk Factors & Reliable Breakout Forecasts - newser.com
Using Python tools to backtest Beta Bionics Inc. strategiesEntry Point & Step-by-Step Swing Trade Plans - newser.com
What analysts say about Beta Bionics Inc stockEx-Dividend Date Alerts & Learn to Pick Stocks in Under 10 Minutes - earlytimes.in
What Fibonacci levels say about Beta Bionics Inc. reboundWeekly Market Report & AI Forecasted Entry/Exit Points - newser.com
How to manage a losing position in Beta Bionics Inc.Weekly Stock Recap & Weekly High Conviction Trade Ideas - newser.com
How to forecast Beta Bionics Inc. trends using time seriesExit Point & Risk Adjusted Swing Trade Ideas - newser.com
Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025 - GlobeNewswire
Relative strength of Beta Bionics Inc. in sector analysisTrend Reversal & High Conviction Trade Alerts - newser.com
How Beta Bionics Inc. stock reacts to bond yieldsRate Hike & Precise Swing Trade Entry Alerts - newser.com
Beta Bionics, Inc. (NASDAQ:BBNX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Beta Bionics Inc Stock Analysis and ForecastDouble Top/Bottom Patterns & Exceptional Capital Growth - earlytimes.in
Live market analysis of Beta Bionics Inc.Quarterly Trade Review & Free Low Drawdown Momentum Trade Ideas - newser.com
Is this a good reentry point in Beta Bionics Inc.2025 Top Decliners & Free Risk Controlled Daily Trade Plans - newser.com
Will Beta Bionics Inc. stock deliver strong dividend growth2025 Price Momentum & Advanced Technical Signal Analysis - newser.com
Beta Bionics Inc. stock volume spike explainedInsider Selling & Weekly Top Gainers Trade List - newser.com
Goldman Sachs Upgrades Beta Bionics (BBNX) - Nasdaq
How institutional ownership impacts Beta Bionics Inc. stockMarket Volume Summary & High Conviction Buy Zone Picks - newser.com
Goldman Sachs Upgrades Beta Bionics to Buy From Neutral, Adjusts Price Target to $26 From $18 - MarketScreener
Goldman Sachs upgrades Beta Bionics stock to Buy on diabetes tech growth By Investing.com - Investing.com South Africa
Goldman Sachs upgrades Beta Bionics stock to Buy on diabetes tech growth - Investing.com
Top chart patterns to watch in Beta Bionics Inc.Weekly Trend Report & High Conviction Buy Zone Picks - newser.com
Beta Bionics Inc Stock (BBNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Beta Bionics Inc Stock (BBNX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Feider Stephen | Chief Financial Officer |
Oct 03 '25 |
Sale |
21.69 |
4,982 |
108,076 |
44,041 |
| Feider Stephen | Chief Financial Officer |
Oct 01 '25 |
Option Exercise |
5.10 |
15,018 |
76,592 |
59,059 |
| Feider Stephen | Chief Financial Officer |
Oct 01 '25 |
Sale |
20.76 |
15,018 |
311,806 |
44,041 |
0.01%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):